Nearly 3 in 10 elite footballers at top clubs have undetected lung and airway problems, study finds

New research from the University of Kent has discovered that nearly three in 10 elite footballers at top clubs in England have undetected lung and airway problems that could impair their on-field performance.

The findings of this study will be presented at a British Thoracic Society meeting on 8 December (details in Notes to Editors) by lead researcher Anna Jackson, who will also call for all top football clubs to implement a lung health screening programme to help identify those with airway problems and treat them appropriately.

The research, which was conducted with colleagues at London's Royal Brompton Hospital, assessed the airway health and impact of treatment in 97 elite male footballers undergoing pre-season fitness and medical screening. It discovered that high rates of previously undiagnosed exercise-induced asthma (EIA) existed among those tested.

Footballers are traditionally screened for potential heart problems using rigorous medical tests but Ms Jackson and colleagues recommend that this should also be the case for lung and breathing issues. Not only would it improve the lung health of players, it also has the potential to increase the players' performance.

They also suggest that clubs need to implement a more rigorous lung health screening programme pre-season using core medical tests and to move beyond looking ad-hoc at possible symptoms, as sometimes these may not always be obvious - or even 'written off' as poor fitness or short term 'coughs and colds'.

It is often the case that in some clubs footballers who are very short of breath or who cough a lot after training may be deemed as not being 'fit enough', when in fact they may have problems with their airways that need to be treated.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients